A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
City of Hope Medical Center
Mayo Clinic
DL Analytics
National Cancer Institute, Naples
Corcept Therapeutics
Memorial Sloan Kettering Cancer Center
Arsenal Biosciences, Inc.
Marengo Therapeutics, Inc.
Tongji Hospital
University of Utah
National Institutes of Health Clinical Center (CC)
Karolinska Institutet
Sorlandet Hospital HF
Peking Union Medical College Hospital
Mabwell (Shanghai) Bioscience Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University
Sichuan Cancer Hospital and Research Institute
Xi'an Jiaotong University
Advaxis, Inc.
Duke University
Kaiser Permanente
Sheba Medical Center
Rigshospitalet, Denmark
Clovis Oncology, Inc.
Hoosier Cancer Research Network
Catalysis SL
Zhejiang Cancer Hospital
Women's College Hospital
Medstar Health Research Institute
Jiangsu Cancer Institute & Hospital
KU Leuven
Wake Forest University Health Sciences
University of Michigan
Novartis
University of Chicago
Tesaro, Inc.
Eli Lilly and Company
Eli Lilly and Company
Amgen
Eli Lilly and Company